By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Nigeria Health OnlineNigeria Health OnlineNigeria Health Online
Notification Show More
Font ResizerAa
  • News
    • Breaking News
  • Features
    • Sam Eferaro Week
  • World Health
  • Pharma News
  • General News
  • Lassa Fever Alert
  • Diabetes Portal
  • Ask the Doctor
Reading: Kenya introduces pre-exposure anti-retroviral drug
Share
Font ResizerAa
Nigeria Health OnlineNigeria Health Online
Search
Have an existing account? Sign In
Follow US
Nigeria Health Online > Blog > BREAKING NEWS > Kenya introduces pre-exposure anti-retroviral drug
BREAKING NEWSNEWS

Kenya introduces pre-exposure anti-retroviral drug

Sam EFERAROESam
Last updated: March 23, 2017 2:58 am
Sam EFERARO
ESam
Published: March 23, 2017
Share
The new drug
SHARE

… To be distributed free to people at risk of HIV infection

The new drug

The Kenyan Government has introduced a new drug for people who, though are HIV negative, are mostly at risk of HIV infection.

The drug, referred to as a Pre-Exposure Prophylaxis (PrEP) which will be distributed free to Kenyans aged 15 years and above is expected to be launched across the country next month.

The roll out is expected to allow Kenyans who require anti-retroviral medicines (ART) to access them to prevent themselves from the risk of acquiring HIV.

Kenya is the second country to embrace the programme in Africa after South Africa. The programme is also found in the United States and Britain.

According to Dr. Martin Sirengo, head of Kenya’s  National AIDS & STI Control Programme (NASCOP), PrEP is an anti-retroviral drug taken daily by HIV negative people most at risk of HIV infection to reduce their chances of becoming infected.

“If you have exposed yourself to HIV, for example,  by having unprotected sex with someone who is living with HIV or coming into contact with infected body fluid, taking PrEP correctly can stop the virus from establishing itself in your body,” Sirengo said.
He added that if used consistently, it can significantly reduce the risk of getting HIV from unprotected sex.

“It is more effective when used with condoms, safer sex practices and other HIV prevention methods, but it is not a vaccine.”

He listed “serodiscordant” couples, where one person is HIV-positive while the other is HIV-negative and those who have used post-exposure prophylaxis (PEP) as the groups targeted mainly for the drug.  Others include people who have multiple sex partners or who engage in transactional sex, victims of sexual violence or those who,  in the course of having sex realise the condom has burst and those who have had repeated treatment of sexually transmitted diseases (STDs).

Dr. Sarah Masyuko, NASCOP ‘s HIV testing and PrEP manager said the regime involves taking a pill daily for the duration one feels he or she is at risk.

“We are working with county governments in some select public facilities to provide the service free of charge. But the drug will not be bought off the counter. It will only be available in the select public health facilities. You must be 15 years and above and you must visit a public hospital to be tested for HIV. If you are negative, then you qualify,”

Dr. Masyuo said people will be tested for the proper functioning of their liver and kidney before taking the drug.

Source: Standardmedia

You Might Also Like

Enter 2018
Nigeria targets higher contraceptive prevalence rate
Report faults FG’s zero allocation for family planning as 3rd quarter ends
NMA urges police to upgrade medical services
FG re-affirms commitment to combat Measles
TAGGED:anti-retroviral medicinesHIVKenyaNASCOPpre-Exposure ProphylaxisPREPSTDs
Share This Article
Facebook Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Categories

  • ES Money
  • U.K News
  • The Escapist
  • Insider
  • Science
  • Technology
  • LifeStyle
  • Marketing

About US

We influence 20 million users and is the number one business and technology news network on the planet.

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

[mc4wp_form]
© Foxiz News Network. Ruby Design Company. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?